UPGRADES BofA/Merrill Lynch lifts Orexigen Therapeutics (Nasdaq: OREX) from Netural to Buy and raised their price target from $3 to $5.
RBC Capital boosts Silver Wheaton (NYSE: SLW) from Sector Perform to Outperform, increasing its price target from $50 to $57.
Ticonderoga raises Charles Schwab Corp. (NYSE: SCHW) from Neutral to Buy, with a $22 price target.